Group 1 n = 10 (15–39 years, Nonimmunocompromised) | Group 2 n = 48 (40–64 years Nonimmunocompromised) | Group 3 n = 116 (> = 65 years, Nonimmunocompromised) | Group 4 n = 107 (> = 15 years Immunocompromised) | |
---|---|---|---|---|
Variable | n/Na (%) | n/Na (%) | n/Na (%) | n/Na (%) |
Female | 3/10 (30) | 10/48 (21) | 46/116 (40) | 44/107 (41) |
BMI | ||||
Normal or Healthy Weight (18.5 – 24.9) | 5/7 (71) | 24/42 (57) | 57/95 (60) | 47/97 (48) |
Overweight (25.0 and Above) | 0/7 (0) | 11/42 (26) | 12/95 (13) | 17/97 (18) |
Underweight (Below 18.5) | 2/7 (29) | 7/42 (17) | 26/95 (27) | 33/97 (34) |
Smoking history | 5/9 (56) | 26/44 (59) | 49/100 (49) | 48/95 (51) |
Alcohol abuse | 2/9 (22) | 13/43 (30) | 13/103 (13) | 11/95 (12) |
Preceding influenza | 0/4 (0) | 2/34 (6) | 8/83 (10) | 1/66 (2) |
Vaccination history of PPSV23 | 0/8 (0) | 1/40 (3) | 6/91 (7) | 9/85 (11) |
Comorbidities | 1/10 (10) | 25/48 (52) | 69/116 (59) | 107/107 (100) |
Clinical presentation | ||||
Bacteremia without any focus | 1/10 (10) | 4/48 (8) | 12/116 (10) | 29/107 (27) |
Meningitis | 3/10 (30) | 9/48 (19) | 18/116 (16) | 14/107 (13) |
Bacteremic pneumonia | 6/10 (60) | 27/48 (56) | 80/116 (69) | 54/107 (50) |
Othersb | 0/10 (10) | 8/48 (17) | 6/116 (5) | 10/107 (9) |
Outcomec | ||||
Fatal | 0/10 (0) | 6/48 (13) | 18/116 (16) | 31/107 (29) |
Serotype | ||||
PCV13 type | 4/10 (40) | 27/48 (56) | 65/116 (56) | 34/107 (32) |
PPSV23 type | 7/10 (70) | 38/48 (79) | 85/116 (73) | 55/107 (51) |